ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionRanger Investment Management, L.P.
Latest Disclosed Ownership360,083 shares
Latest Disclosed Value $ 27,690,383
Ranger Investment Management, L.P. reports 0.63% decrease in ownership of ANIP / ANI Pharmaceuticals, Inc.

On May 15, 2026 - Ranger Investment Management, L.P. filed a 13F-HR form disclosing ownership of 360,083 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $27,690,383 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 362,378 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of -0.63% during the quarter. The current value of the position is $27,089,044 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANI Pharmaceuticals COM 00182C103 360,083 -2,295 -0.63 27,690 -3.20 2.0035
2026-02-13 2025-12-31 13F ANI Pharmaceuticals COM 00182C103 362,378 91,033 33.55 28,606 15.09 1.9621
2025-11-05 2025-09-30 13F ANI Pharmaceuticals COM 00182C103 271,345 -262,888 -49.21 24,855 -28.70 1.7329
2025-08-19 2025-06-30 13F ANI Pharmaceuticals COM 00182C103 534,233 -37,405 -6.54 34,859 -8.92 2.4343
2025-05-15 2025-03-31 13F ANI Pharmaceuticals COM 00182C103 571,638 -6,100 -1.06 38,271 19.83 2.7351
2025-02-13 2024-12-31 13F ANI Pharmaceuticals COM 00182C103 577,738 -11,950 -2.03 31,937 -9.22 2.0164
2024-11-04 2024-09-30 13F ANI Pharmaceuticals COM 00182C103 589,688 186,954 46.42 35,181 37.18 2.2574
2024-08-14 2024-06-30 13F ANI Pharmaceuticals COM 00182C103 402,734 530 0.13 25,646 -7.76 1.7449
2024-05-15 2024-03-31 13F ANI Pharmaceuticals COM 00182C103 402,204 -32,413 -7.46 27,804 16.02 1.7880
2024-02-14 2023-12-31 13F ANI Pharmaceuticals COM 00182C103 434,617 7,769 1.82 23,965 -3.30 1.4530
2023-11-14 2023-09-30 13F ANI Pharmaceuticals COM 00182C103 426,848 -18,309 -4.11 24,783 3.42 1.6455
2023-08-14 2023-06-30 13F ANI Pharmaceuticals COM 00182C103 445,157 319,601 254.55 23,963 380.49 1.4423
2023-05-05 2023-03-31 13F ANI Pharmaceuticals COM 00182C103 125,556 4,370 3.61 4,987 2.30 0.3342
2023-02-14 2022-12-31 13F ANI Pharmaceuticals COM 00182C103 121,186 2,676 2.26 4,875 27.99 0.3619
2022-11-14 2022-09-30 13F ANI Pharmaceuticals COM 00182C103 118,510 -2,131 -1.77 3,809 6.43 0.2990
2022-08-15 2022-06-30 13F ANI Pharmaceuticals COM 00182C103 120,641 2,840 2.41 3,579 8.09 0.2709
2022-05-13 2022-03-31 13F ANI Pharmaceuticals COM 00182C103 117,801 7,050 6.37 3,311 -35.12 0.2093
2022-02-11 2021-12-31 13F ANI Pharmaceuticals COM 00182C103 110,751 25 0.02 5,103 40.42 0.2787
2021-11-15 2021-09-30 13F ANI Pharmaceuticals COM 00182C103 110,726 5,785 5.51 3,634 -1.20 0.1939
2021-08-16 2021-06-30 13F ANI Pharmaceuticals COM 00182C103 104,941 -440 -0.42 3,678 -3.41 0.1920
2021-05-17 2021-03-31 13F ANI Pharmaceuticals COM 00182C103 105,381 -1,421 -1.33 3,808 22.76 0.2096
2021-02-12 2020-12-31 13F ANI Pharmaceuticals COM 00182C103 106,802 -17,961 -14.40 3,102 -11.87 0.1635
2020-11-16 2020-09-30 13F ANI Pharmaceuticals COM 00182C103 124,763 55,527 80.20 3,520 57.21 0.2239
2020-08-14 2020-06-30 13F ANI Pharmaceuticals COM 00182C103 69,236 -27,875 -28.70 2,239 -43.40 0.1534
2020-05-15 2020-03-31 13F ANI Pharmaceuticals COM 00182C103 97,111 6,772 7.50 3,956 -28.99 0.3480
2020-02-14 2019-12-31 13F ANI Pharmaceuticals COM 00182C103 90,339 -3,325 -3.55 5,571 -18.39 0.3674
2019-11-14 2019-09-30 13F ANI Pharmaceuticals COM 00182C103 93,664 3,524 3.91 6,826 -7.88 0.4894
2019-08-14 2019-06-30 13F ANI Pharmaceuticals COM 00182C103 90,140 3,623 4.19 7,410 21.42 0.5051
2019-05-15 2019-03-31 13F ANI Pharmaceuticals COM 00182C103 86,517 6,665 8.35 6,103 69.76 0.4413
2019-02-14 2018-12-31 13F ANI Pharmaceuticals COM 00182C103 79,852 9,640 13.73 3,595 -9.45 0.2932
2018-11-14 2018-09-30 13F ANI Pharmaceuticals COM 00182C103 70,212 10,212 17.02 3,970 -0.95 0.2620
2018-08-14 2018-06-30 13F ANI Pharmaceuticals COM 00182C103 60,000 10,783 21.91 4,008 39.90 0.2802
2018-05-15 2018-03-31 13F ANI Pharmaceuticals COM 00182C103 49,217 9,730 24.64 2,865 12.57 0.2115
2018-02-13 2017-12-31 13F ANI Pharmaceuticals COM 00182C103 39,487 2,593 7.03 2,545 31.39 0.1870
2017-11-14 2017-09-30 13F ANI Pharmaceuticals COM 00182C103 36,894 14,280 63.15 1,937 83.08 0.1453
2017-08-14 2017-06-30 13F ANI Pharmaceuticals COM 00182C103 22,614 7,084 45.61 1,058 37.58 0.0754
2017-05-15 2017-03-31 13F ANI Pharmaceuticals COM 00182C103 15,530 15,530 769 0.0558
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.